Literature DB >> 17384411

Sp-1 binds promoter elements that are regulated by retinoblastoma and regulate CTP:phosphocholine cytidylyltransferase-alpha transcription.

Claudia Banchio1, Susanne Lingrell, Dennis E Vance.   

Abstract

The retinoblastoma (Rb) protein is implicated in transcriptional regulation of at least five cellular genes. Co-transfection of Rb and truncated promoter constructs has defined a discrete element (retinoblastoma control element (RCE)) within the promoters of each of these genes as being necessary for Rb-mediated transcriptional control. In the present report we demonstrate that two RCEs identified within the CTP:phosphocholine cytidylyltransferase-alpha (CTalpha) proximal promoter are essential to promote transcription. Mutations that abolished each RCE markedly decreased CTalpha transcription. Co-transfection of Rb and truncated promoter constructs demonstrated that Rb regulates CTalpha expression by different mechanisms depending on the phase of the cell cycle. The regulation of CTalpha expression by Rb required both the Sp1 and the RCEs. Maximal expression occurred when both Rb and Sp1 were overexpressed. Moreover, RCEs were required for Rb association with the DNA. This regulatory mechanism alters CTalpha activity and thereafter changes PC availability and cell physiology. This is the first report demonstrating not only that surrounding Sp1 binding sites alter regulation mediated by Rb, but also that the expression of a gene involved in PC biosynthesis shares a common regulatory pathway with genes responsible for cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384411     DOI: 10.1074/jbc.M700527200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein.

Authors:  M Z Khan; R Brandimarti; S Shimizu; J Nicolai; E Crowe; O Meucci
Journal:  Cell Death Differ       Date:  2008-06-27       Impact factor: 15.828

3.  Retinoblastoma protein modulates the inverse relationship between cellular proliferation and elastogenesis.

Authors:  Sanjana Sen; Severa Bunda; Junyan Shi; Andrew Wang; Thomas F Mitts; Aleksander Hinek
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

Review 4.  Choline metabolism in malignant transformation.

Authors:  Kristine Glunde; Zaver M Bhujwalla; Sabrina M Ronen
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

5.  N-Myc and SP regulate phosphatidylserine synthase-1 expression in brain and glial cells.

Authors:  Guergana Tasseva; Laura Cole; Jean E Vance
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

6.  Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.

Authors:  Claudia Andreu-Vieyra; Ruihong Chen; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-07-03

7.  The Rb1 tumour suppressor gene modifies telomeric chromatin architecture by regulating TERRA expression.

Authors:  I Gonzalez-Vasconcellos; R Schneider; N Anastasov; S Alonso-Rodriguez; B Sanli-Bonazzi; J L Fernández; M J Atkinson
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

8.  A Rb1 promoter variant with reduced activity contributes to osteosarcoma susceptibility in irradiated mice.

Authors:  Michael Rosemann; Iria Gonzalez-Vasconcellos; Tanja Domke; Virginija Kuosaite; Ralf Schneider; Markus Kremer; Jack Favor; Michaela Nathrath; Michael J Atkinson
Journal:  Mol Cancer       Date:  2014-08-04       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.